References
- PJ Delves, and IM Riott. (2000). The immune system. N Eng J Med 343 (37-49):108–117.
- JR Vane, YS Bakhle, and RM Botting. (1998). Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38:97–120.
- JV Ryn, G Trummlitz, and M Pairet. (2000). COX-2 selectivity and inflammatory processes. Curr Med Chem 7:1145–1161.
- M Beuck. (1999). Nonsteroidal anti-inflammatory drugs: A new generation of cyclooxygenase inhibitors. Angew Chem Int Ed 38:631–633.
- KR Gans, W Galbraith, RJ Roman, SB Haber, JS Kerr, WK Schmidt, C Smith, WE Hewes, and NR Ackerman. (1990). Anti-inflammatory and safety profile of DuP 697, a novel orally effective prostaglandin synthesis inhibitor. J Pharmacol Exp Ther 254:180–187.
- AD Pillai, PD Rathod, FP Xavier, M Patel, M Nivsarkar, KK Vasu, H Padh, and V Sudarsanam. (2003). Novel drug designing approach for dual inhibitors as anti-inflammatory agents: Implication of pyridine template. J Biochem Biophys Res Commun 301:183–186.
- KI Molvi, KK Vasu, MM Patel, V Sudarsanam, and N Haque. (2006). Design and synthesis of bioisosteric tetrasubstituted thiophenes as novel anti-inflammatory agents: Part-I. Ethiop Pharm J 24:1–11.
- KI Molvi, KK Vasu, SG Yerande, V Sudarsanam, N Haque. Syntheses of new tetrasubstituted thiophenes as novel anti- inflammatory agents. Eur J Med Chem, 2007;42:1049–1058.
- KI Molvi, MM Patel, V Sudarsanam, N Haque. Design, synthesis and pharmacological evaluation of novel tetrasubstituted thiophene analogues as anti-inflammatory agents. J Enz Inhib Med Chem, 2008; e pub ahead of print.
- JE Hodgkins, and WP Reeves. (1964). The modified Kaluza synthesis III. The synthesis of some aromatic isothiocyanates. J Org Chem 29:3098–3099.
- WP Reeves, A SimmonsJr, JA Rudis, and TC Bothwell. (1981). Phase transfer catalysis preparation of acyl isothiocyanates. Synth Commun 11:781–785.
- CF Koelsch. (1950). Bromination of 3-acetocoumarin. J Am Chem Soc 72:2993–2995.
- CA Winter, EA Risley, and GW Nuss. (1962). Carrageenan-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proc Soc Exp Biol Med 111:544–547.
- EA Siegmund, RA Cadmus, and G Lu. (1957). A method for evaluating both nonnarcotic and narcotic analgesics. Proc Soc Exp Biol 95:729–731.
- N Sreejayan, and MNA Rao. (1997). Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49:105–107.
- M Ghate, RA Kusanur, and MV Kulkarni. (2005). Synthesis and in vivo analgesic and anti-inflammatory activity of some bi heterocyclic coumarin derivatives. Eur J Med Chem 40:882–887.
- C Kontogiorgis, and D Hadjipavlou-Litina. (2003). Biological evaluation of several coumarin derivatives designed as possible anti-inflammatory/antioxidant agents. J Enz. Inhib Med Chem 18:63–69.
- M Ghate, D Manohar, V Kulkarni, R Shobha, and SY Kattimani. (2003). Synthesis of vanillin ethers from 4-(bromomethyl) coumarins as anti-inflammatory agents. Eur J Med Chem 38:297–302.
- TO Johnson, J Ermolieff, and MR Jirousek. (2002). Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discovery 1:696–709.
- DC Rees, M Congreve, CW Murray, and R Carr. (2004). Fragment-based lead discovery. Nat Rev Drug Discovery 3:660–673.